v3.26.3
Common Stock and Stock-Based Compensation (Tables)
9 Months Ended
Sep. 26, 2026
Share-Based Payment Arrangement [Abstract]  
Summary of Stock Options under Employee Equity Incentive Plan and Stock Option Plan for Non-Employee Directors

Information related to stock options under the Restated Employee Equity Incentive Plan and the Stock Option Plan for Non-Employee Directors and upper management is summarized as follows:

 

 

 

Shares

 

 

Weighted-
Average
Exercise Price

 

 

Weighted-
Average
Remaining
Contractual
Term in Years

 

 

Aggregate
Intrinsic
Value
(in thousands)

 

Vested and expected to vest at December 27, 2025

 

 

289,550

 

 

$

313.93

 

 

 

 

 

 

 

Granted

 

 

4,146

 

 

 

181.63

 

 

 

 

 

 

 

Exercised

 

 

(3,120

)

 

 

157.58

 

 

 

 

 

 

 

Forfeited/ Expired

 

 

(125,231

)

 

 

387.22

 

 

 

 

 

 

 

Outstanding at September 26, 2026

 

 

165,345

 

 

$

258.06

 

 

 

7.37

 

 

$

121

 

Exercisable at September 26, 2026

 

 

82,171

 

 

$

282.78

 

 

 

5.86

 

 

$

121

 

Vested and expected to vest at September 26, 2026

 

 

156,054

 

 

$

264.29

 

 

 

7.18

 

 

$

121

 

 

Summary of Vesting Activities of Shares Issued Under Investment Share Program and Restricted Stock Units

The following table summarizes vesting activities of shares issued under the investment share program and restricted stock units:

 

 

 

Number of Shares

 

 

Weighted Average Fair Value

 

Non-vested at December 27, 2025

 

 

229,603

 

 

$

265.97

 

Granted

 

 

65,928

 

 

 

209.31

 

Vested

 

 

(62,339

)

 

 

303.73

 

Forfeited

 

 

(47,108

)

 

 

251.34

 

Non-vested at September 26, 2026

 

 

186,084

 

 

$

236.95

 

 

Stock-Based Compensation Expense Included in Operating Expenses

The following table provides information regarding stock-based compensation expense included in operating expenses in the accompanying condensed consolidated statements of comprehensive operations:

 

 

 

Thirteen weeks ended

 

 

Thirty-nine weeks ended

 

 

 

September 26,
2026

 

 

September 27,
2025

 

 

September 26,
2026

 

 

September 27,
2025

 

 

 

(in thousands)

 

 

(in thousands)

 

Amounts included in advertising, promotional and selling expenses

 

$

1,742

 

 

$

1,687

 

 

$

5,148

 

 

$

5,691

 

Amounts included in general and administrative expenses

 

 

1,914

 

 

 

1,797

 

 

 

9,978

 

 

 

8,717

 

Total stock-based compensation expense

 

$

3,656

 

 

$

3,484

 

 

$

15,126

 

 

$

14,408

 

Weighted Average Assumptions used to Estimate Fair Value of Shares Purchased

Weighted average assumptions used to estimate fair values of stock options on the date of grants and shares purchased under the Company's investment share program are as follows:

 

 

 

2026

 

Expected volatility

 

 

37.3

%

Risk-free interest rate

 

 

3.7

%

Expected dividends

 

 

0.0

%

Exercise factor

 

 

2.0

 

Discount for post-vesting restrictions

 

 

0.0

%